These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 19584385)

  • 1. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clevidipine for the treatment of severe hypertension in adults.
    Nguyen HM; Ma K; Pham DQ
    Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clevidipine: a short-acting intravenous dihydropyridine calcium channel blocker for the management of hypertension.
    Erickson AL; DeGrado JR; Fanikos JR
    Pharmacotherapy; 2010 May; 30(5):515-28. PubMed ID: 20412001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
    Aronson S
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):465-72. PubMed ID: 19419254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.
    Pollack CV; Varon J; Garrison NA; Ebrahimi R; Dunbar L; Peacock WF
    Ann Emerg Med; 2009 Mar; 53(3):329-38. PubMed ID: 18534716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for treatment of patients with acute severe hypertension answers to the march 2009 journal club questions.
    Barrett TW; Schriger DL
    Ann Emerg Med; 2009 Aug; 54(2):301-7. PubMed ID: 19616729
    [No Abstract]   [Full Text] [Related]  

  • 9. Clevidipine butyrate: a promising new drug for the management of acute hypertension.
    Bergese SD; Puente EG
    Expert Opin Pharmacother; 2010 Feb; 11(2):281-95. PubMed ID: 20088748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clevidipine (Cleviprex) for IV treatment of severe hypertension.
    Med Lett Drugs Ther; 2008 Sep; 50(1295):73-4. PubMed ID: 18800023
    [No Abstract]   [Full Text] [Related]  

  • 11. Lercanidipine in the treatment of hypertension.
    Beckey C; Lundy A; Lutfi N
    Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience.
    Bekker A; Didehvar S; Kim S; Golfinos JG; Parker E; Sapson A; Haile M; Kline R; Lee M
    J Neurosurg Anesthesiol; 2010 Oct; 22(4):330-5. PubMed ID: 20622687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clevidipine : a state-of-the-art antihypertensive drug under the scope.
    Espina IM; Varon J
    Expert Opin Pharmacother; 2012 Feb; 13(3):387-93. PubMed ID: 22251017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clevidipine: a new intravenous option for the management of acute hypertension.
    Ndefo UA; Erowele GI; Ebiasah R; Green W
    Am J Health Syst Pharm; 2010 Mar; 67(5):351-60. PubMed ID: 20172984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of clevidipine in hypertension management: clinical results].
    Zuleta-Alarcón A; Castellón-Larios K; Bergese S
    Rev Esp Anestesiol Reanim; 2014 Dec; 61(10):557-64. PubMed ID: 25236947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ECLIPSE trials: comparative studies of clevidipine to nitroglycerin, sodium nitroprusside, and nicardipine for acute hypertension treatment in cardiac surgery patients.
    Aronson S; Dyke CM; Stierer KA; Levy JH; Cheung AT; Lumb PD; Kereiakes DJ; Newman MF
    Anesth Analg; 2008 Oct; 107(4):1110-21. PubMed ID: 18806012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs.
    Ericsson H; Tholander B; Björkman JA; Nordlander M; Regårdh CG
    Drug Metab Dispos; 1999 May; 27(5):558-64. PubMed ID: 10220482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aliskiren for renin inhibition: a new class of antihypertensives.
    Van Tassell BW; Munger MA
    Ann Pharmacother; 2007 Mar; 41(3):456-64. PubMed ID: 17341529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clevidipine in adult cardiac surgical patients: a dose-finding study.
    Bailey JM; Lu W; Levy JH; Ramsay JG; Shore-Lesserson L; Prielipp RC; Brister NW; Roach GW; Jolin-Mellgard A; Nordlander M
    Anesthesiology; 2002 May; 96(5):1086-94. PubMed ID: 11981147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.